Acne Vulgaris
📧 Sign up to get email alerts when something new happens for Acne Vulgaris.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2013-05-14FDA Approved: RETIN-A — Supplemental Application (Bausch Health US, LLC)
The FDA approved a supplemental application for RETIN-A (tretinoin) submitted by Bausch Health US, LLC.
-
CLINICAL_TRIALS research · 2013-05-03Clinical Trial Update: The Effect of「GTT-EGCG」on Acne Women [NA]
Clinical trial update on the effect of GTT-EGCG on acne in women. Sponsored by National Yang Ming Chiao Tung University, the study targets a…
-
FDA approval · 2013-03-25FDA Approved: ZENATANE — Original Application (BluePoint Laboratories)
FDA approved ZENATANE (isotretinoin) from BluePoint Laboratories under its original application (ANDA 202099). It is indicated for the treat…
-
CLINICAL_TRIALS trial_result · 2013-03-05Clinical Trial Update: Safety and Efficacy Of Drospirenone and Ethinyl Estradiol vs Placebo in the Treatment of Truncal Acne [Phase 3]
A Phase 3 trial assessed drospirenone/ethinyl estradiol versus placebo for acne vulgaris (truncal acne). The study has completed and results…
-
FDA approval · 2013-03-04FDA Approved: ZIANA — Supplemental Application (Bausch Health US, LLC)
The FDA approved a supplemental application for ZIANA (clindamycin phosphate and tretinoin) submitted by Bausch Health US, LLC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2013-02-25Clinical Trial Update: An Extension Study to Assess the Safety, Tolerability, Efficacy, and Treatment Adherence of Dapsone in Acne Vulgaris [Phase 1]
An extension Phase 1 trial evaluating dapsone for acne vulgaris has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2013-02-20Clinical Trial Update: A Study of JNJ 10229570-AAA to Evaluate Safety and Tolerability in Japanese Participants With Acne Vulgaris [Phase 1]
The Phase 1 study of JNJ 10229570-AAA completed in Japanese participants with acne vulgaris to evaluate safety and tolerability.
-
FDA approval · 2013-02-15FDA Approved: EPIDUO — Supplemental Application (Galderma Laboratories, L.P.)
FDA approved a supplemental application for EPIDUO (adapalene and benzoyl peroxide) submitted by Galderma Laboratories, L.P.
-
CLINICAL_TRIALS trial_result · 2013-02-11Clinical Trial Update: Evaluate Therapeutic Equivalence and Safety of Two Clindamycin Phosphate and Benzoyl Peroxide Gels in Acne Vulgaris [Phase 3]
Completed Phase 3 trial evaluating therapeutic equivalence and safety of two clindamycin phosphate and benzoyl peroxide gel formulations for…
-
FDA approval · 2013-02-01FDA Approved: EPIDUO — Supplemental Application (Galderma Laboratories, L.P.)
The FDA approved a supplemental application for Epiduo, the acne medication combining adapalene and benzoyl peroxide, submitted by Galderma …
-
CLINICAL_TRIALS trial_result · 2013-01-10Clinical Trial Update: Effects of Acleara Needle Insert on Acne [NA]
The trial evaluated the effects of the Acleara Needle Insert on acne vulgaris. The study status is completed.
-
FDA label_change · 2013-01-08FDA Approved: TRETINOIN CREAM — Supplemental Application (Obagi Cosmeceuticals LLC)
FDA approved a supplemental NDA for Tretinoin Cream from Obagi Cosmeceuticals LLC, resulting in changes to the product labeling.
-
FDA approval · 2013-01-08FDA Approved: RETIN-A MICRO — Supplemental Application (Bausch Health US LLC)
The FDA approved a supplemental application for RETIN-A MICRO (tretinoin) submitted by Bausch Health US LLC.
-
FDA approval · 2012-12-18FDA Approved: ACANYA — Supplemental Application (Bausch Health US, LLC)
The FDA approved a supplemental application for Acanya (clindamycin phosphate and benzoyl peroxide) from Bausch Health US, LLC, updating the…
-
CLINICAL_TRIALS trial_result · 2012-12-17Clinical Trial Update: Clinical Study Between Two 1% Clindamycin/5% Benzoyl Peroxide Topical Gel Formulations [NA]
A completed clinical trial evaluating two 1% clindamycin/5% benzoyl peroxide topical gel formulations for acne vulgaris; results posted in 2…
-
CLINICAL_TRIALS withdrawal · 2012-11-19Clinical Trial Update: Pharmacokinetics Study of Dapsone-Adapalene Fixed Combination Gel in Acne [Phase 1]
Phase 1 pharmacokinetics study of a dapsone-adapalene fixed combination gel for acne was withdrawn.
-
FDA approval · 2012-10-24FDA Approved: TRETINOIN — Original Application (Endo USA, Inc.)
FDA approved tretinoin as a generic product under an Original Application from Endo USA, Inc.
-
CLINICAL_TRIALS trial_result · 2012-10-23Clinical Trial Update: Efficacy of Zingiber Officinalis (Homoeopathic Medicine) in Treatment of Acne Vulgaris [Phase 1]
Phase 1 trial evaluating the efficacy of Zingiber Officinalis (homeopathic ginger) in acne vulgaris. The study status is completed.
-
CLINICAL_TRIALS trial_result · 2012-10-23Clinical Trial Update: Efficacy of Azadirachta Indica (Homoeopathic Medicine) in Treatment of Acne Vulgaris [Phase 1]
Phase 1 trial completed evaluating the efficacy of Azadirachta indica (homeopathic medicine) for acne vulgaris.
-
CLINICAL_TRIALS trial_result · 2012-10-23Clinical Trial Update: A Comparative Study of the Tolerability of Two Combination Therapies for the Treatment of Acne [Phase 4]
Phase 4 clinical trial comparing tolerability of two combination therapies for acne vulgaris. The study is completed and results were posted…
-
CLINICAL_TRIALS trial_result · 2012-10-01Clinical Trial Update: BLI1100 for the Treatment of Moderate to Severe Acne Vulgaris [Phase 2]
Phase 2 trial of BLI1100 for moderate to severe acne vulgaris has completed.
-
CLINICAL_TRIALS trial_result · 2012-09-25Clinical Trial Update: Efficacy and Safety Study of Finacea to Treat Acne Vulgaris and Post-Inflammatory Hyperpigmentation (PIH) [Phase 4]
Phase 4 study updating the efficacy and safety of Finacea (azelaic acid) for acne vulgaris and post-inflammatory hyperpigmentation, with res…
-
CLINICAL_TRIALS trial_result · 2012-09-19Clinical Trial Update: EGCG Improves Acne by Modulating Molecular Targets [NA]
Completed clinical trial evaluating epigallocatechin gallate (EGCG) for improving acne by modulating molecular targets.
-
CLINICAL_TRIALS trial_result · 2012-09-12Clinical Trial Update: Safety and Efficacy of Tazarotene Cream 0.1% Compared With Adapalene Gel 0.3% in the Treatment of Moderate to Severe Facial Acne Vulgaris [Phase 4]
A Phase 4 study comparing tazarotene cream 0.1% to adapalene gel 0.3% for moderate-to-severe facial acne vulgaris was terminated with result…
-
CLINICAL_TRIALS trial_result · 2012-09-10Clinical Trial Update: Clinical Trial on the Effects and Side Effects of ProOxy in the Treatment of Acne [Phase 1]
Phase 1 clinical trial evaluating the effects and side effects of ProOxy in treating acne vulgaris. The trial was sponsored by Medivet Pty L…